首页> 外国专利> COMPOSITIONS AND METHODS FOR THE TREATMENT OF SUBSTANCE USE DISORDERS, ADDICTION, AND PSYCHIATRIC DISORDERS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SUBSTANCE USE DISORDERS, ADDICTION, AND PSYCHIATRIC DISORDERS

机译：用于治疗药物使用障碍，成瘾和精神障碍的组合物和方法

页面导航

摘要
著录项
相似文献

摘要

The present invention features a composition comprising a first agent and a second agent for treating disorder associated with aberrant activity in the HPA axis like an addiction to a substance (e.g., cocaine, amphetamines, methamphetamine, methylphenidate, heroin, coedine, hydrocodone, nicotine, alcohol, prescription medication (e.g., Percodan®, Percoset®), marijuana, tobacco, methadone, food), addiction to an activity (e.g., gambling, sex, eating), substance use disorders, mood disorders, anxiety disorders, bipolar disorder, sleep disorders, insomnia, posttraumatic stress syndrome, borderline personality disorder, disruptive behavior disorders, ADHD, major depressive disorder, burnout, chronic fatigue syndrome, fibromyalgia, irritable bowel syndrome, eating disorders (e.g., Prader Willi Syndrome), obesity, depression, menopause, prementsrual syndrome (PMS), obsessive compulsive disorder (OCD), social anxiety, generalized anxiety disorder, dysthymia, or schizophrenia.

机译：本发明的特征在于一种组合物，其包含用于治疗与HPA轴中异常活性相关的病症（例如对物质（例如可卡因，苯丙胺，甲基苯丙胺，哌醋甲酯，海洛因，可可碱，氢可酮，尼古丁，酒精，处方药（例如Percodan®，Percoset®），大麻，烟草，美沙酮，食物），对某项活动（例如赌博，性，饮食）上瘾，物质使用障碍，情绪障碍，焦虑症，双相情感障碍，睡眠障碍，失眠，创伤后应激障碍综合症，边缘型人格障碍，破坏性行为障碍，多动症，重度抑郁症，倦怠，慢性疲劳综合症，纤维肌痛，肠易激综合症，进食障碍（例如普拉德·威利综合症），肥胖，抑郁，更年期，食前综合征（PMS），强迫症（OCD），社交焦虑症，广泛性焦虑症，心境障碍或精神分裂症。

著录项

公开/公告号US2019282583A1

专利类型
公开/公告日2019-09-19

原文格式PDF
申请/专利权人 EMBERA NEUROTHERAPEUTICS INC.;
展开▼

申请/专利号US201916433543
发明设计人 MICHAEL DETKE;MARTIN PHILLIPS;ROBERT LINKE;
展开▼

申请日2019-06-06
分类号A61K31/53;A61P25/30;A61K31/519;A61K31/506;A61K31/4196;A61K45/06;A61K31/4168;A61K31/343;A61K31/138;A61K31/496;A61K31/4188;
国家 US
入库时间 2022-08-21 12:12:59

相似文献

专利
外文文献
中文文献